Lyka Labs
₹106.1
-1.45 (-1.35%)
29 March, 2024 16:29 BSE: 500259
NSE: LYKALABSISIN: INE933A01014
Start SIP in Lyka Labs
Start SIPLyka Labs Performance
Day Range
- Low 106
- High 109
52 Week Range
- Low 89
- High 144
- Open Price106
- Previous Close108
- Volume72495
Lyka Labs Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 31 | 27 | 21 | 19 |
Operating Expenses Qtr Cr | 26 | 23 | 19 | 17 |
Operating Profit Qtr Cr | 6 | 4 | 3 | 3 |
Depreciation Qtr Cr | 3 | 3 | 3 | 3 |
Interest Qtr Cr | 1 | 1 | 1 | 3 |
Tax Qtr Cr | 1 | 0 | 0 | 0 |
Net Profit Qtr Cr | 1 | 0 | -2 | -3 |
Lyka Labs Technicals
EMA & SMA
Current Price
₹106.1
-1.45 (-1.35%)
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹113.37
- 50 Day
- ₹118.37
- 100 Day
- ₹119.55
- 200 Day
- ₹119.07
- 20 Day
- ₹114.34
- 50 Day
- ₹120.74
- 100 Day
- ₹121.82
- 200 Day
- ₹117.67
Lyka Labs Resistance and Support
PIVOT
₹106.9
Resistance | |
---|---|
First Resistance | 108.15 |
Second Resistance | 110.20 |
Third Resistance | 111.45 |
RSI | 31.17 |
MFI | 35.17 |
MACD Single Line | -3.91 |
MACD | -4.37 |
Support | |
---|---|
First Resistance | 104.85 |
Second Resistance | 103.60 |
Third Resistance | 101.55 |
Lyka Labs Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 84,491 | 5,947,321 | 70.39 |
Week | 107,236 | 8,770,853 | 81.79 |
1 Month | 97,375 | 7,674,086 | 78.81 |
6 Month | 154,361 | 9,314,154 | 60.34 |
Lyka Labs Result Highlights
Lyka Labs Synopsis
NSE-Medical-Generic Drugs
Lyka Labs is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 80.59 Cr. and Equity Capital is Rs. 30.69 Cr. for the Year ended 31/03/2023. Lyka Labs Ltd. is a Public Limited Listed company incorporated on 29/12/1976 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1976PLC008738 and registration number is 008738.Market Cap | 351 |
Sales | 99 |
Shares in Float | 1.49 |
No of funds | 15 |
Yield |
Book Value | 4.26 |
U/D Vol ratio | 1.2 |
LTDebt / Equity | 82 |
Alpha | -0.08 |
Beta | 0.78 |
Lyka Labs
Owner Name | Dec-23 | Sep-23 | Jun-23 | Apr-23 |
---|---|---|---|---|
Promoters | 54.81% | 54.81% | 54.58% | 54.56% |
Mutual Funds | 0.01% | 0.01% | 0.01% | 2.69% |
Insurance Companies | 0.4% | 0.4% | 0.4% | 0.4% |
Foreign Portfolio Investors | 0.17% | 0.18% | 0.17% | 0.17% |
Financial Institutions/ Banks | ||||
Individual Investors | 34.32% | 35.5% | 35.56% | 33.03% |
Others | 10.29% | 9.1% | 9.28% | 9.15% |
Lyka Labs Management
Name | Designation |
---|---|
Mr. Babulal Jain | Chairman |
Mr. Kunal Gandhi | Managing Director & CEO |
Mr. Yogesh B Shah | Executive Director & CFO |
Mr. Sandeep P Parikh | Independent Director |
Mrs. Dhara P Shah | Independent Director |
Mr. Prashant Godha | Non Executive Director |
Mr. Shashil Mendosa | Non Executive Director |
Lyka Labs Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Lyka Labs Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-02-08 | Quarterly Results | |
2023-11-02 | Quarterly Results | |
2023-08-02 | Quarterly Results | |
2023-05-23 | Audited Results | |
2023-04-18 | Others |
Lyka Labs FAQs
What is Share Price of Lyka Labs ?
Lyka Labs share price is ₹106 As on 29 March, 2024 | 16:15
What is the Market Cap of Lyka Labs ?
The Market Cap of Lyka Labs is ₹351.1 Cr As on 29 March, 2024 | 16:15
What is the P/E ratio of Lyka Labs ?
The P/E ratio of Lyka Labs is -105.9 As on 29 March, 2024 | 16:15
What is the PB ratio of Lyka Labs ?
The PB ratio of Lyka Labs is 7.7 As on 29 March, 2024 | 16:15